Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

QLT Gets New Lease On Life With Multi-Pronged Deals

Executive Summary

The Canadian drug developer will be in a position to advance its lead retinoid asset and be an acquirer of choice, according to management, after completing a series of deals, including the acquisition of InSite Vision and an investment in a new company, Aralez Pharmaceuticals.

Advertisement

Related Content

QLT Shows Off Its Assets In Hopes Of Attracting A Suitor

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS056972

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel